access Archives - Rabin Martin | Ideas change health

Utilizing technology to accelerate the time to diagnosis for children with a rare disease

The 28th of February marked Rare Disease Day—a global event where hundreds of patient organizations work to raise awareness of rare disease. While, by definition, an individual rare disease affects a small number of people, when taken together, it is estimated that rare diseases affect 300-350 million people worldwide and almost 30 million in ...

The new health economy, the private sector and the road to universal health coverage

Today is Universal Health Coverage Day. A new book edited by Rabin Martin’s Jeffrey L. Sturchio, Ilona Kickbusch (Graduate Institute of International and Development Studies, Geneva) and Louis Galambos (Johns Hopkins University) provides a range of insights into the extent and impact of the global health economy and how private firms are contributing to ...

Thinking differently about how to harness healthcare markets

Rabin Martin President & CEO Jeff Sturchio’s recent contribution to the British Medical Journal discusses how thinking differently about how to harness health markets could provide more health for more people. The article, “The global healthcare markets” — delves into the complex global health economy and challenges in adapting health systems to provide more ...

Spotlight on oncology: Increasing access to patient-centered cancer care

As the global burden of disease shifts from infectious to chronic, non-communicable diseases, health systems and industry are tackling these challenges by focusing on how to provide personalized, patient-centered care to all people who need it, while considering issues around cost and value of innovation. Having just returned from the World Cancer Congress in ...

Bridge2Care: Training U.S. health care workers to bring HIV-positive patients into care

Merck & Co., Inc. posed a challenge: How could the company help dramatically improve the health of people with HIV in the U.S.? We conducted in-depth research and engaged more than 100 thought leaders and service providers to envision an optimal system in which everyone at-risk was tested, everyone infected promptly entered care – and then stayed there.

What is the Just Price for Modern Cancer Drugs?

That’s the question which continues to reverberate from the recent week article in the hematology journal Blood rejecting the high prices of treatments for CML (chronic myeloid leukemia).

Expanding adolescent mental health screening

The United States routinely screens teens for vision and hearing loss, but not for a mental illness. For more than a decade, we worked with the TeenScreen National Center for Mental Health Checkups at Columbia University to expand teen mental health screening to 43 states. Now major insurers, primary care providers and more than 500 schools and community organizations offer a free mental health check-up for teenagers.

Diabetes: Rethinking Novo Nordisk’s global strategy for access to care

Novo Nordisk came to us with a question: How could the company help improve access to diabetes care for patients around the world? We initiated a comprehensive re-assessment of the company’s access strategy, benchmarked novel approaches and gained feedback from more than 40 stakeholders, helping Novo Nordisk identify the opportunity to build on its legacy as the leading diabetes company in the world by working to close the global gap in access to insulin.

Thanks for your interest!